Team Blog


  • First-hand innovation

    I read about Kylie Simonds this week, who may not be as famous as the other Kylie but who at 11-years old…

  • The night we lost the intern

    Once a month the cycling enthusiasts within Team head out for an evening ride which takes in a couple of the lovely pubs in vicinity to our barn. We call it Wobbly Wednesday.

  • Smart move for smart lenses

    In a press release in July 2014, Swiss pharmaceutical colossus Novartis announced their partnership with Google…

Similar People


Jonathan Bainbridge, Human Factors Consultant

Jonathan Bainbridge
Senior Human Factors Consultant

Read more

Jonathan is responsible for the management, planning and implementation of human factors and user research studies for Team’s clients, and as part of Team’s product development process…

Kay Newell, Senior Consultant

Kay Newell
Senior Consultant

Read more

Kay is a senior consultant in the Human Factors/User Research group, responsible for the management, planning and implementation of formative and summative research studies.

Occoris-concept-being-used-

Ground-breaking inhaler engine unlocks new markets beyond asthma

Today we have released feasibility test results for our innovative Occoris® inhaler engine concept, demonstrating a significant improvement in the efficiency of drug delivery to the deep lung compared to typical dry powder inhaler (DPI) devices.
David Harris, Principal Consultant

Polarised trends at RDD 2012

Some 600 delegates braved the heat of the Arizona desert to attend the...
Disposable inhaler concept, based on Occoris technology

Revolutionary Occoris inhaler engine to make debut at RDD

Designed primarily for delivering systemic treatments beyond the typically inhaled topical asthma and COPD, such as vaccines, pain relief and insulin, the Occoris™ ‘engine’ is ultra-small, active and achieves very accurate and repeatable delivery of API-only formulations.
Max Middleton, Senior Consultant

What does ISO 20072 mean in practice?

The new ISO20072 standard for inhalers was published a few years ago...
prohaler_150x150

New Inhaler Delivers Simplicity with Enhanced Drug Delivery Performance

A new Dry Powder Inhaler (DPI), designed and developed by Valois Pharma with the support of Team Consulting, was presented for the first time at the recent Drug Delivery to the Lungs Conference in Edinburgh. Whilst offering excellent delivery performance, the Prohaler™ was designed from the outset with the user in mind and is completely intuitive to use.

Team and Valois Pharmaceutical Division partner on new dry powder inhaler development

Team Consulting and Valois Pharmaceutical Division today announced they have embarked upon a major development programme to produce a novel breath-actuated multi-dose Dry Powder Inhaler (DPI). The 'Bead Inhaler' will utilise a unique dispersion technology proven to deliver excellent aerosolisation performance, reproducible emitted dose and high fine particle fraction. A novel drug storage and release technology is also being developed. In addition to offering excellent delivery performance and moisture protection with a wide range of formulations, the inhaler will be compact and simple to use.